Sarepta Therapeutics, Inc 10-Q for FY2022 Q3
Sarepta Therapeutics, Inc. (SRPT)
10-Q
2022-11-02
For: 2022-09-30
View Original
Added on
April 11, 2026
About this 10-Q
Sarepta Therapeutics, Inc filed this 10-Q on November 2, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).
Headline figures
Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $230.27M
- up 21.6% from $189.41M a year earlier
- Net loss
- $257.74M
- compared with a net loss of $48.14M a year earlier
- Diluted EPS
- -$2.94
- compared with -$0.60 a year earlier